EARLY MOBILIZATION OF INTUBETED PATIENTS IN THE INTENSİVE CARE UNİT AND THE EFFECTS OF EARLY MOBILIZATION ON RESPIRATORY PATTERN AND PATIENT HEMODYNAMICS

December 6, 2021 updated by: Gürkan ÇAMOK, Okan University
The present study was carried out as a quasi-experimental study in order to examine the effects of early mobilization of intubated patients in the intensive care unit and the effects of early mobilization on respiratory pattern and patient hemodynamics. The sample of the study consisted of 25 intubated patients monitored in the intensive care unit at in a private hospital between May 2020 and July 2021. Ethics committee approval and study permission were obtained from the hospital before starting the data collection process. Research data, descriptive data collection form, Richmond- Agitation Sedation Scale (RASS) scale, Muscle Strength Testing (Oxford Scale) and with the mobilization of the patients 45 minute in 30-60 minute including the preparation process, (1st Stage Semi Fowler position, 2nd Stage bedside sitting position, 3rd Stage in the bedside sitting position after mobilization) were registered in the Early Mobilization Follow-up Form and collected. Number and percentage calculations, repeated measurement ANOVA and Post Hoc Sheffe, LSD test analyzes were utilized in the evaluation of the data.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • İ̇stanbul
      • Istanbul, İ̇stanbul, Turkey, 34959

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

INTUBE PATIENTS IN ICU

Description

Inclusion Criteria:

  • 18 years and over,
  • Hemodiamic stability (OCD >60, OCD <120, respiratory rate <35, SpO2 >90),
  • Areas of >3/5 (Oxford scale) and above on the lower limbs with areas of secure support,
  • The patient scores 0 (awake and calm) on the Richmond Agitation Sedation Scale (RASS),
  • PaO2 / FiO2 ≥300,
  • Body temperature below 38 degrees,
  • Platelet count ≥20,000 cells / mm3,
  • Having blood sugar of 60-360 mg/dl,
  • Having arterial monitoring,
  • Patient with 30% FiO2 due to mechanical ventilator,
  • Those with mechanical ventilator-dependent ventilation method (mode) PASB,
  • Patient with a PEEP value of 5 due to mechanical ventilator,
  • Patient with a PASB value of 10 connected to a mechanical ventilator,
  • A sample accepted by the patient who voluntarily agreed to participate in the study was approximated from the patient.

Exclusion Criteria:

  • Patients under the age of 18,
  • Those with hemodynamic instability (OCD <60 mmHg, OCD >120 mmHg, breath rate >35, SpO2 <90),
  • Those who do not have secure unsupported sitting balance and have a score of >3/5 (Oxford scale) in the lower limbs,
  • Patients whose Richmond agitation sedation scale (RASS) is between +1 and +4 points, and patients with a score between -1 and -5,
  • Those with arrhythmia,
  • Patients without arterial monitoring,
  • Patients whose FiO2 percentage is not 30% in patients on mechanical ventilator,
  • Patients who do not have ventilation method (mod) PASB in patients on mechanical ventilator,
  • Patients who do not have a PEEP value of 5 in patients on mechanical ventilators,
  • Patients who do not have a PASB value of 10 in patients on mechanical ventilators,
  • Those with neurological and orthopedic contraindications,
  • Patients who could not get approval from the relatives of the patients who did not accept to participate in the study were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
INTENSIVE CARE PATIENTS
EARLY MOBILIZATION OF INTUBE PATIENTS
EARLY MOBILIZATION OF INTUBE PATIENTS AND ITS EFFECTS OF MOBILIZATION

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EARLY MOBILIZATION OF INTUBE PATIENTS AND THE EFFECTS OF EARLY MOBLIZATION ON RESPIRATORY PATTERN AND PATIENT HEMODYNAMICS
Time Frame: ONE DAY
HEMODYNAMIC EFFECTSRESPIRATORY PATTERN, BLOOD GAS ANALYSISZ
ONE DAY

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 10, 2021

Primary Completion (Anticipated)

February 1, 2022

Study Completion (Anticipated)

March 1, 2022

Study Registration Dates

First Submitted

December 6, 2021

First Submitted That Met QC Criteria

December 6, 2021

First Posted (Actual)

December 20, 2021

Study Record Updates

Last Update Posted (Actual)

December 20, 2021

Last Update Submitted That Met QC Criteria

December 6, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • GURKANCAMOK

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

all of

Study Data/Documents

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intensive Care Unit Acquired Weakness

Clinical Trials on MOBILIZATION

Subscribe